LY 311727

Discontinued Product

LY 311727 (Cat. No. 3627) has been withdrawn from sale for commercial reasons.
Cat.No. 3627 - LY 311727 | C22H27N2O5P | CAS No. 164083-84-5
Description: Selective secreted phospholipase A2 (sPLA2) inhibitor
Chemical Name: [3-[[3-(2-Amino-2-oxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-5-yl]oxy]propyl]-phosphonic acid
Purity: ≥97% (HPLC)
Datasheet
Citations (1)
Reviews
Literature

Biological Activity

Selective secreted phospholipase A2 (sPLA2) inhibitor (IC50 values are <1 μM for group IIA and <50 μM for group V). Attenuates VEGF-mediated platelet-activating factor (PAF) synthesis in BAEC and HUVEC cells at a concentration of 100 μM.

Technical Data

M. Wt 430.43
Formula C22H27N2O5P
Storage Store at +4°C
Purity ≥97% (HPLC)
CAS Number 164083-84-5
PubChem ID 155922
InChI Key OPWQYOUZRHDKBR-UHFFFAOYSA-N
Smiles NC(CC2=C(CC)N(CC3=CC=CC=C3)C1=CC=C(OCCCP(O)(O)=O)C=C12)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

All Tocris products are intended for laboratory research use only.

Product Datasheets

Certificate of Analysis / Product Datasheet
Select another batch:
Safety Datasheet

References

References are publications that support the biological activity of the product.

Schevitz et al (1995) Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Nat.Struct.Biol. 2 429 PMID: 7664101

Bernatchez et al (2001) VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2. Br.J.Pharmacol. 134 197 PMID: 11522612

Bridonneau et al (1997) High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnps-PLA2). J.Med.Chem 41 778

View Related Products by Target

View Related Products by Product Action

View all Phospholipase Inhibitors

Keywords: LY 311727, LY 311727 supplier, LY311727, secreted, phospholipases, a2, sPLA2, PLA2, inhibitors, inhibits, Phospholipases, 3627, Tocris Bioscience

1 Citation for LY 311727

Citations are publications that use Tocris products. Selected citations for LY 311727 include:

Mock et al (2013) Evidence for distinct mechanisms of uptake and antitumor activity of secretory phospholipase A2 responsive liposome in prostate cancer. Integr Biol (Camb) 5 172 PMID: 22890797


Reviews for LY 311727

There are currently no reviews for this product. Be the first to review LY 311727 and earn rewards!

Have you used LY 311727?

Submit a review and receive an Amazon gift card.

$10US/$10CAN/€7/£6 gift card for a review without an image

$25US/$25CAN/€18/£15 gift card for a review with an image

*Offer only valid in the USA / Canada, UK and Europe

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Cancer

Cancer Research Product Guide

A collection of over 750 products for cancer research, the guide includes research tools for the study of:

  • Cancer Metabolism
  • Epigenetics in Cancer
  • Receptor Signaling
  • Cell Cycle and DNA Damage Repair
  • Angiogenesis
  • Invasion and Metastasis
Cardiovascular

Cardiovascular Research Product Guide

A collection of over 250 products for cardiovascular research, the guide includes research tools for the study of:

  • Hypertension
  • Thrombosis and Hemostasis
  • Atherosclerosis
  • Myocardial Infarction
  • Ischemia/Reperfusion Injury
  • Arrhythmias
  • Heart Failure
Asthma

Asthma Poster

Asthma is one of the most common chronic diseases in the world, affecting over 300 million people. This poster highlights key pathways and new therapies used to treat the condition, including those currently in clinical development.